POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 67 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,746 | +40.3% | 91,490 | +3.8% | 0.00% | – |
| Q2 2023 | $155,179 | -92.3% | 88,170 | -86.5% | 0.00% | – |
| Q1 2023 | $2,006,294 | +39.2% | 651,394 | +139.5% | 0.00% | – |
| Q4 2022 | $1,441,473 | +88.2% | 271,976 | +25.3% | 0.00% | – |
| Q3 2022 | $766,000 | +233.0% | 217,001 | +543.4% | 0.00% | – |
| Q4 2021 | $230,000 | +75.6% | 33,726 | +87.4% | 0.00% | – |
| Q3 2021 | $131,000 | -14.4% | 18,000 | +17.6% | 0.00% | – |
| Q2 2021 | $153,000 | -67.0% | 15,300 | -68.4% | 0.00% | – |
| Q1 2021 | $463,000 | – | 48,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |